Short Antibiotics Match Outcomes in Pneumonia
Only about one in ten hospitalized patients qualified for shorter therapy in a large US analysis
By
Kathryn Wighton
April 14, 2026
Clinical Scorecard: Short Antibiotics Match Outcomes in Pneumonia
At a Glance
Category Detail
Condition Community-acquired pneumonia in hospitalized patients
Key Mechanisms Shorter antibiotic courses (3-4 days) versus longer courses (median 7 days) in clinically stable patients
Target Population Hospitalized adult patients with community-acquired pneumonia who achieve clinical stability by day 3
Care Setting General care hospital wards
Key Highlights
Mortality was less than 1% and similar between short- and longer-duration antibiotic groups. Readmission rates, urgent health care visits, and Clostridioides difficile infection rates were comparable between groups. Short-course therapy was uncommon, with fewer than 10% of eligible patients receiving 3 to 4 days of antibiotics.
Guideline-Based Recommendations
Diagnosis
Identify clinical stability by day 3 using normal vital signs, adequate oxygenation, and normal mental status.
Management
Consider shorter antibiotic courses (3-4 days) for hospitalized patients with community-acquired pneumonia who are clinically stable by day 3. Avoid prolonged antibiotic courses in uncomplicated pneumonia responding to treatment.
Monitoring & Follow-up
Monitor for clinical stability indicators and adverse events during antibiotic therapy. Follow patients for at least 30 days post-treatment for readmission and infection surveillance.
Risks
Residual confounding and low event rates may limit precision of outcomes. Findings may not apply to critically ill patients or those with significant comorbidities. Observational study design may be influenced by unmeasured patient differences.
Patient & Prescribing Data
Hospitalized adults with community-acquired pneumonia achieving clinical stability by day 3
Only about 10% of patients met eligibility for short-course therapy; despite guideline support, most receive longer antibiotic durations.
Clinical Best Practices
Assess clinical stability rigorously by day 3 to identify candidates for shorter antibiotic courses. Adopt guideline-supported shorter antibiotic durations in eligible patients to reduce unnecessary antibiotic exposure. Be cautious in generalizing findings to patients with severe illness or multiple comorbidities. Recognize that antibiotic-associated adverse events and Clostridioides difficile infections are uncommon and similar between short and longer courses.
References